Anika Therapeutics (ANIK) Short-term Investments (2014 - 2026)
Anika Therapeutics (ANIK) posted quarterly Short-term Investments of $25.8 million for Q1 2026, up 17.2% year-over-year from $22.0 million in Q1 2025, and up 8.77% quarter-over-quarter from $23.7 million in Q4 2025.
Anika Therapeutics (ANIK) Short-term Investments (2014 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Short-term Investments for 13 consecutive years, with $25.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Short-term Investments rose 17.2% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $25.8 million (up 17.2% YoY), while the FY2025 annual figure was $23.7 million, changed 0.41% from the prior year.
- Short-term Investments climbed to $25.8 million in Q1 2026 per ANIK's latest filing, from $23.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $36.7 million in Q2 2023 and bottomed at $22.0 million in Q1 2025.
- Historically, Short-term Investments has averaged $29.1 million across 5 years, with a median of $29.3 million in 2022.
- Annual changes were most pronounced in 2025 — Short-term Investments sank 31.46% — and 2026, when it climbed 17.2%.
- Anika Therapeutics' Short-term Investments stood at $34.6 million in 2022, then decreased by 23.87% to $26.4 million in 2023, then retreated by 10.49% to $23.6 million in 2024, then climbed by 0.41% to $23.7 million in 2025, then grew by 8.77% to $25.8 million in 2026.
- Business Quant data shows ANIK's Short-term Investments at $25.8 million in Q1 2026, $23.7 million in Q4 2025, and $22.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.77 Mn |
| Dec 31, 2025 | 23.69 Mn |
| Sep 30, 2025 | 22.19 Mn |
| Jun 30, 2025 | 23.96 Mn |
| Mar 31, 2025 | 21.99 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 28.36 Mn |
| Jun 30, 2024 | 33.77 Mn |
| Mar 31, 2024 | 32.08 Mn |
| Dec 31, 2023 | 26.36 Mn |
| Sep 30, 2023 | 34.68 Mn |
| Jun 30, 2023 | 36.74 Mn |
| Mar 31, 2023 | 30.63 Mn |
| Dec 31, 2022 | 34.63 Mn |
| Sep 30, 2022 | 34.17 Mn |
| Jun 30, 2022 | 32.17 Mn |
| Mar 31, 2022 | 29.31 Mn |
| Dec 31, 2021 | 29.84 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 20.54 Mn |